When you have an innovative product and smart people in a team, discussions are bound to happen—and that's a good thing. It's your fuel for growth. My co-founder Bogdan Nesvit and I are working on the ...
PURCHASE, N.Y., Aug. 12, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (CGTX), (the Company or Cognition) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative ...
The Company will conduct two Phase 3 clinical trials of nalbuphine ER for the treatment of patients with IPF-related chronic cough First pivotal trial is on track to initiate in the second quarter of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results